WIPO General Assembly 2014: Decision Paragraph on the Design Law Treaty-Decision punted till 2015

On 30 September 2014, the WIPO secretariat handed the following text relating to the “Consideration of the Convening of a Diplomatic Conference for the Adoption of a Design Law Treaty (DLT).”

Consideration of the Convening of a Diplomatic Conference for the Adoption of a Design Law Treaty (DLT)

Agenda item 14 Decision Paragraph

The WIPO General Assembly:

Will at its session in September 2015 decide on whether to convene a diplomatic conference for the adoption of a Design Law Treaty as soon as practicable.”

Continue Reading

Uncategorized

WIPO General Assembly 2014: Draft decision on item 16 (IGC on genetic resources, traditional knowledge & folklore)

On 30 September 2014, the WIPO secretariat handed the following draft decision relating to the WIPO Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore (IGC).

GA 2014

Draft decision on item 16

The WIPO General Assembly:

(1)) took note of the information contained in document WO/GA/46/6;

(2) took note of the statements made by delegations at the Forty-Sixth Session of the WIPO General Assembly in 2014; and

Continue Reading

Uncategorized

WIPO General Assembly 2014: No Decision Reached on the Work of the Standing Committee on Copyright and Related Rights (SCCR)

On Tuesday, 30 September 2014, the Secretariat handed out the following text:

Matters relating to the Standing Committee on Copyright and Related Rights (SCCR) Agenda item 15 Decision Paragraph

The WIPO General Assembly

(i) took note of the information contained in document WO/GA/46/5; and

(ii) took note of the statements made by delegations at the 46th session of the WIPO General Assembly in 2014.

Continue Reading

Uncategorized

European Medicines Agency (EMA) recommends approval of Harvoni, Gilead’s all oral HCV combination product

The European Medicines Agency (EMA) is recommending approval of Harvoni, a combination of 9mg of ledipasvir (LDV) and 400mg of sofosbuvir (SOF), for the treatment of chronic hepatitis C virus (HCV) infection in adults. This is the “all oral” combination product, delivered in daily does of just 490 mg of API, for the “cure of patients with chronic HCV infection without the need for treatments involving interferons.”

Continue Reading

Uncategorized

WIPO General Assembly 2014: KEI Statement on the Standing Committee on the Law of Patents

On Thursday, 25 September 2014, Knowledge Ecology International (KEI) delivered this statement on agenda item 17(i), Reports on other WIPO Committees, (i) Standing on the Law of Patents (SCP).

WIPO General Assembly 2014

17. Reports on other WIPO Committees
(i) Standing Committee on the Law of Patents (SCP);

Statement of Knowledge Ecology International

Continue Reading

Uncategorized

WIPO General Assembly 2014: South Africa Intervention on the Standing Committee on the Law of Patents (SCP)

On Thursday, 25 September 2014, South Africa delivered the following intervention on agenda item 17(i) on the Report of the Standing Committee on the Law of Patents (SCP) at the Fifty-Fourth Series of Meetings of the Assemblies of the Member States of WIPO.

South Africa Intervention on the Standing Committee on the Law of Patents (SCP)

Continue Reading

Uncategorized

WIPO General Assembly 2014: KEI statement on Matters Relating to the Standing Committee on Copyright and Related Rights (SCCR)

On Wednesday, 24 September 2014, Knowledge Ecology International delivered this intervention on agenda item 15, Matters Relating to the Standing Committee on Copyright and Related Rights (SCCR)

WIPO General Assembly 2014

15. Matters Relating to the Standing Committee on Copyright and Related Rights (SCCR)

Statement of Knowledge Ecology International

Continue Reading

Uncategorized

WIPO General Assembly 2014: KEI statement on the Report of the Committee on Development and Intellectual Property (CDIP)

On Wednesday, 24 September 2014, Knowledge Ecology International delivered the following statement at the 2014 WIPO General Assembly on agenda item 13, Report of the Committee on Development and Intellectual Property (CDIP) and Review of the Implementation of the Development Agenda Recommendations.

13. Report of the Committee on Development and Intellectual Property (CDIP) and Review of the Implementation of the Development Agenda Recommendations

Statement of Knowledge Ecology International

Continue Reading

Uncategorized

Comments of KEI regarding the White House OSTP call for comments on its Strategy for American Innovation

Comments of KEI regarding the White House OSTP call for comments on its Strategy for American Innovation

(PDF of comments here)

Attn: Dan Correa, Office of Science and Technology Policy, Eisenhower Executive Office Building, 1650 Pennsylvania Ave NW., Washington, DC 20504.
Email: innovationstrategy@ostp.gov.
Re: Strategy for American Innovation
Date: September 23, 2014

Continue Reading

Uncategorized